Sprifermin

N/A

Report date: 2024/05/07 20:00:09

Base Information

Drug NameSprifermin
Drug Alias Nameesprifermina司瑞夫明司利弗明spriferminumsprifermine +[11] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionFibroblast growth factor receptor 2 agonistsFibroblast growth factor receptor 3 agonists
TargetsFibroblast growth factor receptor 2Fibroblast growth factor receptor 3
Therapy Area/IndicationsKnee InjuriesOsteoarthritis, KneeCartilage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[17] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZymogenetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono SaTrialspark IncEmd Serono Inc +[5] 
Active IndicationsN/A
Inactive IndicationsKnee InjuriesOsteoarthritis, KneeCartilage Diseases

Other Information

ATC CodeN/A
Related LinksN/A